Thortec assumes the ongoing development and commercialization of Ireland-based Apica’s platforms. Our experienced M&A professionals teamed up with Irish co-counsel to execute a transaction to combine two enterprises focused on delivering better heart therapies.
Thoratec buys Apica to strengthen market for transcatheter valve replacement devices
Our client Apica Cardiovascular, the developer of a suite of implant systems and devices to aid in aortic valve replacement, was acquired by Thoratec, a world leader in devices to restore failing hearts.